Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Real-world data show that adjuvant therapy, not complete nodal dissection, is crucial for preventing relapse in patients with stage III melanoma.

According to a recent study, researchers are developing nanotechnology that can improve the treatment of one of the most ...

Science, 2011). With the advent of combination therapies, which combine immunotherapy, targeted therapy and chemotherapy to boost efficacy and overcome resistance, the market for treatments for ...

The global Cancer Immunotherapy Market is valued at USD 121.4 Billion in 2024 and is projected to reach a value of USD 294.4 ...

The global CAR T-cell therapy market is on track for rapid growth, with projections indicating it will exceed USD 27.5 billion by 2033, up from USD 2.7 billion in 2025. This exponential rise in market ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Hundreds will benefit after the first targeted treatment for the most common form of bladder cancer was given the green light ...